These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 17876006)

  • 21. The combined effect of rifampin and pyrazinamide within the human macrophage.
    Sbarbaro JA; Iseman MD; Crowle AJ
    Am Rev Respir Dis; 1992 Dec; 146(6):1448-51. PubMed ID: 1456560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Higher activity of morphazinamide over pyrazinamide against intracellular.
    Teyssier L
    Int J Tuberc Lung Dis; 2001 Apr; 5(4):386. PubMed ID: 11334260
    [No Abstract]   [Full Text] [Related]  

  • 23. Intracellular growth and drug susceptibility of Mycobacterium tuberculosis in macrophages.
    Chanwong S; Maneekarn N; Makonkawkeyoon L; Makonkawkeyoon S
    Tuberculosis (Edinb); 2007 Mar; 87(2):130-3. PubMed ID: 16860611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Studies on the effect of antituberculosis agents against tubercle bacilli in the resting state, using streptomycin-dependent strain (18-b). I. Studies in vitro].
    Ota Y
    Kekkaku; 1971 Aug; 46(8):295-301. PubMed ID: 4328204
    [No Abstract]   [Full Text] [Related]  

  • 25. [Antimicrobial resistance in tuberculosis].
    Gutiérrez-Aroca JB; Ruiz P; Casal M
    Rev Esp Quimioter; 2013 Dec; 26(4):332-6. PubMed ID: 24399346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Specificity of antituberculous action in vitro of pyrazine-2-carboxylic acid derivatives].
    Pavlov EP
    Probl Tuberk; 1971; 49(7):76-9. PubMed ID: 5004351
    [No Abstract]   [Full Text] [Related]  

  • 27. Pyrazinamide resistance among drug-resistant Mycobacterium tuberculosis isolates at a referral hospital.
    Arora J; Sidiq Z; Visalakshi P; Bhalla M; Behera D; Myneedu VP
    Diagn Microbiol Infect Dis; 2013 Dec; 77(4):380-1. PubMed ID: 24075630
    [No Abstract]   [Full Text] [Related]  

  • 28. Bactericidal action of pulsed exposure to rifampicin, ethambutol, isoniazid & pyrazinamide on Mycobacterium tuberculosis in vitro.
    Paramasivan CN; Herbert D; Prabhakar R
    Indian J Med Res; 1993 Jul; 97():145-50. PubMed ID: 8406638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential use of nitrate reductase as a biomarker for the identification of active and dormant inhibitors of Mycobacterium tuberculosis in a THP1 infection model.
    Sarkar S; Sarkar D
    J Biomol Screen; 2012 Aug; 17(7):966-73. PubMed ID: 22573731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The effects of antituberculous chemotherapy in vitro under various conditions inadequate for the growth of tubercle bacilli (author's transl)].
    Uratsuji Y
    Bull Chest Dis Res Inst Kyoto Univ; 1978 Mar; 10(1-2):20-9. PubMed ID: 99201
    [No Abstract]   [Full Text] [Related]  

  • 31. [Nutrient starved incubation conditions enhance pyrazinamide activity against Mycobacterium tuberculosis].
    Chen ZF; Huang Q; Li YY; Zhang Y; Ren Y; Li KS; Fu ZJ; Xu SQ
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 May; 30(5):359-62. PubMed ID: 17651643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pyrazinamide resistance determined by liquid culture at low pH better correlates with genetic mutations in MDR tuberculosis isolates.
    Pang Y; Wang Z; Zheng H; Song Y; Wang Y; Zhao Y
    J Microbiol Methods; 2015 Dec; 119():142-4. PubMed ID: 26506283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
    Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM
    Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bactericidal action of gatifloxacin, rifampin, and isoniazid on logarithmic- and stationary-phase cultures of Mycobacterium tuberculosis.
    Paramasivan CN; Sulochana S; Kubendiran G; Venkatesan P; Mitchison DA
    Antimicrob Agents Chemother; 2005 Feb; 49(2):627-31. PubMed ID: 15673743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evaluation of the pyrazinamidase test for the detection of susceptibility of Mycobacterium tuberculosis to pyrazinamide].
    Montoro Cardoso E; López Novo M; Echemendía Font M; Valdivia Alvarez JA
    Rev Cubana Med Trop; 1999; 51(1):53-4. PubMed ID: 10887557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the microscopic observation drug susceptibility assay for detection of Mycobacterium tuberculosis resistance to pyrazinamide.
    Ghiraldi LD; Campanerut PA; Spositto FL; Sato DN; Leite CQ; Hirata M; Hirata RD; Cardoso RF
    Clin Microbiol Infect; 2011 Dec; 17(12):1792-7. PubMed ID: 21595790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early results from indirect drug susceptibility test for tubercle bacilli.
    Mathew S; Narayanan A; Segaran R; Paramasivan CN
    Indian J Med Res; 1999 May; 109():167-9. PubMed ID: 10643140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potentiation of bacterial killing activity of zinc chloride by pyrrolidine dithiocarbamate.
    Choi EK; Lee HH; Kang MS; Kim BG; Lim HS; Kim SM; Kang IC
    J Microbiol; 2010 Feb; 48(1):40-3. PubMed ID: 20221728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A whole blood bactericidal assay for tuberculosis.
    Wallis RS; Palaci M; Vinhas S; Hise AG; Ribeiro FC; Landen K; Cheon SH; Song HY; Phillips M; Dietze R; Ellner JJ
    J Infect Dis; 2001 Apr; 183(8):1300-3. PubMed ID: 11262217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pyrazinamide sterilizing activity in vitro against semidormant Mycobacterium tuberculosis bacterial populations.
    Heifets L; Lindholm-Levy P
    Am Rev Respir Dis; 1992 May; 145(5):1223-5. PubMed ID: 1586071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.